Marie leads the development of Parabilis Medicines’ clinical strategy, design and authorship of clinical trial protocols, provides medical oversight of clinical trials, partners with Clinical Operations to operationalize clinical trials, and provides clinical strategy support for pipeline programs. Marie comes to us from Bristol Myers Squibb, where she was an Executive Director in Early Clinical Development, Hematology/Oncology and Cell Therapy. At BMS, she led over seven programs targeting solid tumors and hematologic malignancies, and drove clinical execution excellence and process optimization as the Founder/Head of the Research and Early Development Clinical Center of Excellence. Prior to BMS, Marie was the Sr. Director, Translational Medicine and Sr. Medical Director at Celgene; Medical Director, Oncology Clinical Research at Janssen; and Assistant Professor, Hematology/Oncology at University of Michigan. Marie completed her B.A., B.S., and M.D. at Stanford University, her residency at the University of Washington, and Hematology/Oncology Fellowship back at Stanford in 2013.